A retrospective analysis of actionable pharmacogenetic/genomic biomarker language in FDA labels

Abstract The primary goal of precision medicine is to maximize the benefit‐risk relationships for individual patients by delivering the right drug to the right patients at the right dose. To achieve this goal, it has become increasingly important to assess gene‐drug interactions (GDIs) in clinical s...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteur: Shinji Yamazaki (Auteur)
Formaat: Boek
Gepubliceerd in: Wiley, 2021-07-01T00:00:00Z.
Onderwerpen:
Online toegang:Connect to this object online.
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

Connect to this object online.

3rd Floor Main Library

Exemplaargegevens van 3rd Floor Main Library
Plaatsingsnummer: A1234.567
Kopie 1 Beschikbaar